Secunderabad Healthcare Ltd.
| BSE: 524540 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE930C01016 |
| BSE 00:00 | 04 Mar | Secunderabad Healthcare Ltd |
| NSE 05:30 | 01 Jan | Secunderabad Healthcare Ltd |
| OPEN | 6.17 |
| PREVIOUS CLOSE | 5.99 |
| VOLUME | 309707 |
| 52-Week high | 6.17 |
| 52-Week low | 0.00 |
| P/E | |
| Mkt Cap.(Rs cr) | 50 |
| Buy Price | 5.77 |
| Buy Qty | 25.00 |
| Sell Price | 6.10 |
| Sell Qty | 492.00 |
Secunderabad Healthcare Ltd. (SECUNDHEALTH) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Cipla | 638.85 | -6.95 | -1.08 | 1888.41 |
| Glenmark Pharma. | 432.60 | -2.60 | -0.60 | 1622.11 |
| Cadila Health. | 366.25 | 3.00 | 0.83 | 1602.10 |
| Lupin | 899.35 | 4.35 | 0.49 | 1538.83 |
| Aurobindo Pharma | 778.30 | -1.40 | -0.18 | 1529.73 |
| Divi's Lab. | 2190.05 | -7.05 | -0.32 | 1332.65 |
| Dr Reddy's Labs | 3920.95 | 1.10 | 0.03 | 1277.30 |
| Alembic Pharma | 896.95 | -3.50 | -0.39 | 969.40 |
| P & G Health Ltd | 4065.30 | 7.55 | 0.19 | 838.72 |
| Sun Pharma.Inds. | 476.90 | 3.75 | 0.79 | 816.60 |
| Alkem Lab | 2352.30 | 2.30 | 0.10 | 799.84 |
| Torrent Pharma. | 2394.70 | 43.75 | 1.86 | 745.42 |
| Natco Pharma | 663.05 | 23.55 | 3.68 | 667.10 |
| Ipca Labs. | 1662.70 | 6.40 | 0.39 | 454.91 |
| Abbott India | 15661.60 | -140.00 | -0.89 | 450.33 |
| Ajanta Pharma | 1411.20 | -16.30 | -1.14 | 441.13 |
| Biocon | 395.55 | 3.65 | 0.93 | 440.90 |
| Pfizer | 4123.80 | -55.60 | -1.33 | 429.05 |
| Sanofi India | 7797.60 | -66.80 | -0.85 | 414.20 |
| Syngene Intl. | 437.20 | 30.95 | 7.62 | 411.50 |
Quick Links for Secunderabad Healthcare:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
